STRIVE - A Multicentre Randomised Controlled Trial of Intravenous Immunoglobulin Versus Standard Therapy for Transverse Myelitis
study details
This multi-center randomized controlled trial evaluates if the addition of intravenous immunoglobulin to standard treatment of corticosteroids improves outcome in children and adults with first episode of Transverse Myelitis of Neuro-myelitis optica. Half of participants will receive corticosteroids alone, whilst the other half will receive corticosteroids plus intravenous immunoglobulin.
more details
https://clinicaltrials.gov/ct2/show/NCT02398994?term=STRIVE&rank=5